Top Industry Leaders in the Klippel Trenaunay Syndrome Treatment Market
Latest Klippel-Trenaunay Syndrome Treatment Companies Updates:
Medtronic Receives FDA Approval for InSeal Embolization System for Arteriovenous Malformations (AVMs): This system offers a minimally invasive approach to treat AVMs, a common complication in KTS patients.
Stryker Develops Embolic Protection Devices for KTS Treatment: Stryker's commitment to expanding its neurovascular portfolio includes devices specifically designed for KTS procedures.
List of Klippel-Trenaunay Syndrome Treatment companies in the market:
- Stryker Corp.
- DePuy Synthes
- Zimmer Biomet
- Smith & Nephew
- Medtronic Spinal
- DJO Global
- Integra Lifesciences
- NuVasive Inc.
- Globus Medical
- Wright Medical
- Pfizer Inc.
- Biocon India Ltd.
- Wyeth Limited